In addition, the natural active monomer EM-2 promoted G2/M phase arrest and apoptosis by activating the JNK pathway in hepatocellular carcinoma cells, which could be partially reversed when treated with the JNK inhibitor SP600125 (9). Here, MAPK8 is linked to hepatocellular carcinoma.